HOPE Archives | XVIVO

Warning: Attempt to read property "ID" on null in /home/xvivogro/public_html/wp-content/plugins/comeet-wp-plugin-Version-3.0.2/comeet.php on line 1385

.block-xps-360 .xps-360-bg{--wpr-bg-c7b95766-80e5-4d5b-aa8e-e6558f16baa8: url('https://www.xvivogroup.com/wp-content/themes/xvivo/assets/images/xps-360/xps_bg.jpg');}.block-xps-360 .product-slider .flex-direction-nav .flex-prev{--wpr-bg-4d24cf75-e077-4317-bdec-f77878721787: url('https://www.xvivogroup.com/wp-content/themes/xvivo/assets/images/xps-360/product_left_arrow.png');}.block-xps-360 .product-slider .flex-direction-nav .flex-next{--wpr-bg-81a05068-14e5-4a34-9cfb-7d704f10cad0: url('https://www.xvivogroup.com/wp-content/themes/xvivo/assets/images/xps-360/product_right_arrow.png');}.block-xps-360 .product-slider .slides .link-1 .read-more,.block-xps-360 .product-slider .slides .link-2 .read-more,.block-xps-360 .product-slider .slides .link-3 .read-more,.block-xps-360 .product-slider .slides .link-4 .read-more,.block-xps-360 .product-slider .slides .link-5 .read-more,.block-xps-360 .product-slider .slides .link-6 .read-more,.block-xps-360 .product-slider .slides .link-7 .read-more,.block-xps-360 .product-slider .slides .link-8 .read-more,.block-xps-360 .product-slider .slides .link-9 .read-more,.block-xps-360 .product-slider .slides .link-10 .read-more,.block-xps-360 .product-slider .slides .link-11 .read-more,.block-xps-360 .product-slider .slides .link-12 .read-more,.block-xps-360 .product-slider .slides .link-13 .read-more,.block-xps-360 .product-slider .slides .link-14 .read-more{--wpr-bg-9d8e7aab-d397-4699-8cca-30dee20bc144: url('https://www.xvivogroup.com/wp-content/themes/xvivo/assets/images/xps-360/plus.png');}.sprite{--wpr-bg-d418ac58-0d09-4a79-ae07-3a52c613823c: url('https://www.xvivogroup.com/wp-content/themes/xvivo/assets/images/icons/sprite.png');}

HOPE

Hypothermic oxygenated perfusion of the donor heart in heart transplantation: the short-term outcome from a randomised, controlled, open-label, multicentre clinical trial

Successful clinical transplantation of hearts donated after circulatory death using direct procurement followed by hypothermic oxygenated perfusion: A report of the first 3 cases.

Improved outcome after hypothermic oxygenated machine perfusion in liver transplantation – Long-term follow-up of a multicenter randomized controlled trial

Successful heart transplant after 12 h preservation aboard a commercial flight

Hypothermic oxygenated machine perfusion reduces early allograft injury and improves post-transplant outcomes in extended criteria donation liver transplantation from donation after brain death: Results from a multicenter randomized controlled trial

Machine perfusion in liver transplantation (Cochrane Review)

Hypothermic machine perfusion as a national standard preservation method for deceased donor kidneys

Oxygenated versus standard cold perfusion preservation in kidney transplantation (COMPARE): a randomised, double-blind, paired, phase 3 trial

A nonrandomized open-label phase 2 trial of nonischemic heart preservation for human heart transplantation

Hypothermic oxygenated perfusion (HOPE) safely and effectively extends acceptable donor heart preservation times: Results of the Australian and New Zealand trial.

A multicenter randomized-controlled trial of hypothermic oxygenated perfusion (HOPE) for human liver grafts before transplantation

Reducing cold ischemia time by donor liver “back-table” preparation under continuous oxygenated machine perfusion of the portal vein.

First comparison of hypothermic oxygenated perfusion versus static cold storage of human donation after cardiac death liver transplants: An international-matched case analysis.